Delayed diagnosis of tuberculosis in persons living with HIV in Eastern Europe: associated factors and effect on mortality-a multicentre prospective cohort study.


Journal

BMC infectious diseases
ISSN: 1471-2334
Titre abrégé: BMC Infect Dis
Pays: England
ID NLM: 100968551

Informations de publication

Date de publication:
06 Oct 2021
Historique:
received: 13 04 2021
accepted: 20 08 2021
entrez: 7 10 2021
pubmed: 8 10 2021
medline: 9 10 2021
Statut: epublish

Résumé

Early diagnosis of tuberculosis (TB) is important to reduce transmission, morbidity and mortality in people living with HIV (PLWH). PLWH with a diagnosis of TB were enrolled from HIV and TB clinics in Eastern Europe and followed until 24 months. Delayed diagnosis was defined as duration of TB symptoms (cough, weight-loss or fever) for ≥ 1 month before TB diagnosis. Risk factors for delayed TB diagnosis were assessed using multivariable logistic regression. The effect of delayed diagnosis on mortality was assessed using Kaplan-Meier estimates and Cox models. 480/740 patients (64.9%; 95% CI 61.3-68.3%) experienced a delayed diagnosis. Age ≥ 50 years (vs. < 50 years, aOR = 2.51; 1.18-5.32; p = 0.016), injecting drug use (IDU) (vs. non-IDU aOR = 1.66; 1.21-2.29; p = 0.002), being ART naïve (aOR = 1.77; 1.24-2.54; p = 0.002), disseminated TB (vs. pulmonary TB, aOR = 1.56, 1.10-2.19, p = 0.012), and presenting with weight loss (vs. no weight loss, aOR = 1.63; 1.18-2.24; p = 0.003) were associated with delayed diagnosis. PLWH with a delayed diagnosis were at 36% increased risk of death (hazard ratio = 1.36; 1.04-1.77; p = 0.023, adjusted hazard ratio 1.27; 0.95-1.70; p = 0.103). Nearly two thirds of PLWH with TB in Eastern Europe had a delayed TB diagnosis, in particular those of older age, people who inject drugs, ART naïve, with disseminated disease, and presenting with weight loss. Patients with delayed TB diagnosis were subsequently at higher risk of death in unadjusted analysis. There is a need for optimisation of the current TB diagnostic cascade and HIV care in PLWH in Eastern Europe.

Sections du résumé

BACKGROUND BACKGROUND
Early diagnosis of tuberculosis (TB) is important to reduce transmission, morbidity and mortality in people living with HIV (PLWH).
METHODS METHODS
PLWH with a diagnosis of TB were enrolled from HIV and TB clinics in Eastern Europe and followed until 24 months. Delayed diagnosis was defined as duration of TB symptoms (cough, weight-loss or fever) for ≥ 1 month before TB diagnosis. Risk factors for delayed TB diagnosis were assessed using multivariable logistic regression. The effect of delayed diagnosis on mortality was assessed using Kaplan-Meier estimates and Cox models.
FINDINGS RESULTS
480/740 patients (64.9%; 95% CI 61.3-68.3%) experienced a delayed diagnosis. Age ≥ 50 years (vs. < 50 years, aOR = 2.51; 1.18-5.32; p = 0.016), injecting drug use (IDU) (vs. non-IDU aOR = 1.66; 1.21-2.29; p = 0.002), being ART naïve (aOR = 1.77; 1.24-2.54; p = 0.002), disseminated TB (vs. pulmonary TB, aOR = 1.56, 1.10-2.19, p = 0.012), and presenting with weight loss (vs. no weight loss, aOR = 1.63; 1.18-2.24; p = 0.003) were associated with delayed diagnosis. PLWH with a delayed diagnosis were at 36% increased risk of death (hazard ratio = 1.36; 1.04-1.77; p = 0.023, adjusted hazard ratio 1.27; 0.95-1.70; p = 0.103).
CONCLUSION CONCLUSIONS
Nearly two thirds of PLWH with TB in Eastern Europe had a delayed TB diagnosis, in particular those of older age, people who inject drugs, ART naïve, with disseminated disease, and presenting with weight loss. Patients with delayed TB diagnosis were subsequently at higher risk of death in unadjusted analysis. There is a need for optimisation of the current TB diagnostic cascade and HIV care in PLWH in Eastern Europe.

Identifiants

pubmed: 34615474
doi: 10.1186/s12879-021-06745-w
pii: 10.1186/s12879-021-06745-w
pmc: PMC8496077
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

1038

Subventions

Organisme : Medical Research Council
ID : MR/T001127/1
Pays : United Kingdom

Investigateurs

A Vassilenko (A)
D Klimuk (D)
O Kondratenko (O)
A Zalutskaya (A)
V Bondarenko (V)
V Mitsura (V)
E Kozorez (E)
O Tumash (O)
O Suetnov (O)
D Paduto (D)
V Iljina (V)
T Kummik (T)
K Mshvidobadze (K)
N Lanchava (N)
L Goginashvili (L)
L Mikiashvili (L)
N Bablishvili (N)
B Rozentale (B)
I Zeltina (I)
I Janushkevich (I)
I Caplinskiene (I)
S Caplinskas (S)
Z Kancauskiene (Z)
A Wiercinska-Drapalo (A)
M Thompson (M)
J Kozlowska (J)
A Grezesczuk (A)
M Bura (M)
B Knysz (B)
M Inglot (M)
A Garlicki (A)
J Loster (J)
D D Uiculescu (DD)
A Rakhmanova (A)
O Panteleev (O)
A Yakovlev (A)
A Kozlov (A)
A Tyukalova (A)
Y Vlasova (Y)
T T Rofimov (TT)
G Kyselyova (G)
N Obel (N)
J Gerstoft (J)
G Kronborg (G)
M C Payen (MC)
K K Abeya (KK)
C Necsoi (C)
F Dabis (F)
A Tsaranazy (A)
C Cazanave (C)
H Furrer (H)
M Sagette (M)
M Rickenbach (M)
D Sculier (D)
A Calmy (A)
M Cavassini (M)
A Bruno (A)
E Bernasconi (E)
M Hoffmann (M)
P Vernazza (P)
J Fehr (J)
R Weber (R)
R Miller (R)
N Vora (N)
G Cooke (G)
S Mullaney (S)
E Wilkins (E)
V George (V)
P Collini (P)
D Dockrell (D)
F Post (F)
L Campbell (L)
R Brum (R)
E Mabonga (E)
P Saigal (P)
S Kegg (S)
J Ainsworth (J)
A Waters (A)
J Dhar (J)
K Ellis (K)
E Girardi (E)
A Rianda (A)
V Galati (V)
C Pinnetti (C)
C Tommasi (C)
G Lapadula (G)
A Di Biagio (A)
A Parisini (A)
S Carbonara (S)
G Angarano (G)
M Purgatorio (M)
A Matteelli (A)
A Apostoli (A)
J M Miro (JM)
C Manzardo (C)
C Ligero (C)
J Gonzalez (J)
Jose A Martinez-Martinez (JA)
F Sanchez (F)
H Knobel (H)
M Salvadó (M)
J L Lopez-Colomes (JL)
X Martínez-Lacasa (X)
E Cuchí (E)
V Falcó (V)
A Curran (A)
M T Tortola (MT)
I Ocaña (I)
R Vidal (R)
M A Sambeat (MA)
V Pomar (V)
P Coll (P)
D Pozamczer (D)
M Saumoy (M)
F Alcaide (F)
J Caylà (J)
A Moreno (A)
J P Millet (JP)
A Orcau (A)
L Fina (L)
A Romero (A)
L L Roldan (LL)
J A Iribarren (JA)
M Ibarguren (M)
S Moreno (S)
A González (A)
P Miralles (P)
T Aldámiz-Echevarría (T)
M Losso (M)
J Toibaro (J)
L Gambardella (L)
J Toibaro (J)
L Moreno Macias (L)
E Warley (E)
S Tavella (S)
O Garcia Messina (O)
O Gear (O)
H Laplume (H)
C Marson (C)
J Contarelia (J)
M Michaan (M)
P Scapellato (P)
B Bartoletti (B)
D Palmero (D)
C Elias (C)
C Cortes (C)
B Crabtree (B)
J L Mosqueda Gomez (JL)
J A Villanueva (JA)
L A Gonzalez Hernandez (LA)
F Badial (F)

Informations de copyright

© 2021. The Author(s).

Références

Int J Tuberc Lung Dis. 2010 Jun;14(6):741-4
pubmed: 20487613
J Clin Med. 2019 Dec 31;9(1):
pubmed: 31906163
HIV Med. 2021 Apr;22(4):283-293
pubmed: 33215809
Int J Tuberc Lung Dis. 2000 Mar;4(3):240-5
pubmed: 10751070
Trop Med Int Health. 2011 Apr;16(4):394-411
pubmed: 21320240
Int J Tuberc Lung Dis. 2006 Apr;10(4):390-5
pubmed: 16602402
Infect Dis Poverty. 2018 Mar 24;7(1):25
pubmed: 29587840
PLoS One. 2012;7(9):e45704
pubmed: 23049842
PLoS One. 2019 Nov 19;14(11):e0225165
pubmed: 31743358
Open Forum Infect Dis. 2019 May 17;6(6):ofz233
pubmed: 31211163
BMC Infect Dis. 2009 Apr 13;9:42
pubmed: 19364398
BMC Infect Dis. 2014 Nov 25;14:624
pubmed: 25421106
Int J Tuberc Lung Dis. 2020 Mar 1;24(3):329-339
pubmed: 32228764
Public Health Action. 2015 Mar 21;5(1):36-44
pubmed: 26400600
BMC Public Health. 2008 Jan 14;8:15
pubmed: 18194573
Int J Tuberc Lung Dis. 2006 Jan;10(1):24-30
pubmed: 16466033
Int J STD AIDS. 2020 Apr;31(5):410-419
pubmed: 32183614
AIDS. 2015 Sep 24;29(15):1987-2002
pubmed: 26266773
Lancet. 2007 Oct 20;370(9596):1453-7
pubmed: 18064739
PLoS One. 2018 Sep 6;13(9):e0203593
pubmed: 30188947
J Int AIDS Soc. 2016 Jan 12;19(1):20714
pubmed: 26765347
Int J Tuberc Lung Dis. 2013 Feb;17(2):214-20
pubmed: 23228464
BMC Pulm Med. 2017 Dec 13;17(1):202
pubmed: 29237451
Trans R Soc Trop Med Hyg. 2008 Aug;102(8):797-804
pubmed: 18513768
J Infect. 2018 Jan;76(1):44-54
pubmed: 29061336
Int J Tuberc Lung Dis. 2018 Mar 1;22(3):280-286
pubmed: 29471905
PLoS One. 2018 Apr 6;13(4):e0195409
pubmed: 29624603
BMC Infect Dis. 2012 Sep 07;12:208
pubmed: 22958583
BMC Infect Dis. 2019 Jan 7;19(1):18
pubmed: 30616533
BMC Infect Dis. 2020 Jun 29;20(1):456
pubmed: 32600284
Lancet HIV. 2016 Mar;3(3):e120-31
pubmed: 26939735
BMJ Open. 2014 Jun 10;4(6):e004818
pubmed: 24916087
BMC Infect Dis. 2018 Oct 26;18(1):536
pubmed: 30367622
Tuberc Res Treat. 2012;2012:827148
pubmed: 22778946
Public Health Action. 2017 Dec 21;7(4):299-303
pubmed: 29584792

Auteurs

Christian Kraef (C)

CHIP (Centre of Excellence for Health, Immunity and Infections), Rigshospitalet, University of Copenhagen, Copenhagen, Denmark. christiankraef@gmail.com.
Department of Infectious Diseases, The Heart Centre, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark. christiankraef@gmail.com.
Heidelberg Institute of Global Health, University of Heidelberg, Heidelberg, Germany. christiankraef@gmail.com.

Adrian Bentzon (A)

CHIP (Centre of Excellence for Health, Immunity and Infections), Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.

Alexander Panteleev (A)

City TB Dispensary, St. Petersburg, Russia.

Alena Skrahina (A)

Republican Scientific and Practical Center for Pulmonology and Tuberculosis, Minsk, Belarus.

Natalie Bolokadze (N)

Infectious Diseases, AIDS and Clinical Immunology Research Center, Tbilisi, Georgia.

Simona Tetradov (S)

Dr Victor Babes' Hospital of Tropical and Infectious Diseases, Bucharest AND 'Carol Davila' University of Medicine and Pharmacy, Bucharest, Romania.

Regina Podlasin (R)

Wojewodski Szpital Zakanzy/Medical University of Warsaw, Warsaw, Poland.

Igor Karpov (I)

Department of Infectious Disease, Belarusian State Medical University, Minsk, Belarus.

Elena Borodulina (E)

Samara State Medical University of the Ministry of Healthcare of the Russian Federation, Samara, Russia.

Elena Denisova (E)

Botkin Hospital of Infectious Disease, St. Petersburg, Russia.

Inga Azina (I)

Riga East University Hospital, Latvian Centre of Infectious Diseases, Riga, Latvia.

Jens Lundgren (J)

CHIP (Centre of Excellence for Health, Immunity and Infections), Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.

Isik Somuncu Johansen (IS)

Research Unit for Infectious Diseases, Odense University Hospital, University of Southern, Odense, Denmark.

Amanda Mocroft (A)

CHIP (Centre of Excellence for Health, Immunity and Infections), Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
Centre for Clinical Research, Epidemiology, Modelling and Evaluation (CREME), Institute for Global Health, UCL, London, UK.

Daria Podlekareva (D)

CHIP (Centre of Excellence for Health, Immunity and Infections), Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.

Ole Kirk (O)

CHIP (Centre of Excellence for Health, Immunity and Infections), Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
Department of Infectious Diseases, The Heart Centre, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
Research Unit for Infectious Diseases, Odense University Hospital, University of Southern, Odense, Denmark.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH